Xilio Therapeutics (XLO) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2026)

Xilio Therapeutics (XLO) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	PP&E (Net) Growth (3y) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	14.05%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	11.65%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	411.50%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-3.34%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	16.78%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	1.66%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	109.44%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	19.96%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Xilio Therapeutics	178.33 Mn	42.29 Mn	-	-20.94%

Download Data